Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06250868 · ClinicalTrials.gov registry record
TRK-3 Performance of Pachymetry
A clinical trial, sponsored by Topcon Corporation.
- Completed
- Registry status
- 30
- Enrollment target
NCT06250868: Completed study, sponsored by Topcon Corporation.
NCT06250868 is a clinical trial that has completed, run by Topcon Corporation. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06250868 has completed, sponsored by Topcon Corporation.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
To evaluate the performance of a new tonometer.
Primary Outcome
Thickness of the cornea
Interventions
- DEVICE Kerato-Refracto Tonometer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-02-20 |
| Est. Completion | 2024-02-26 |
What the finished NCT06250868 record still lists
NCT06250868 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Kerato-Refracto Tonometer is the first listed.
NCT06250868 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06250868 about?
NCT06250868 is a clinical study titled "TRK-3 Performance of Pachymetry". To evaluate the performance of a new tonometer.
What is the current status of trial NCT06250868?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2024-02-20. Estimated completion is 2024-02-26.
What interventions are being tested in trial NCT06250868?
The interventions under investigation include: Kerato-Refracto Tonometer (DEVICE).
Who is sponsoring clinical trial NCT06250868?
This trial is sponsored by Topcon Corporation, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI